MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...

Northern Tool + Equipment is bringing the high-octane excitement of Monster Jam® to the Little Rock community. On Thursday, February 20, customers will have the chance to experience the thrill-seeking ...

PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment ... 1.6 Million Shares ~ RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc ...

One milliliter of culture was added to 100 mL of LB with 30 μg/mL kanamycin monosulfate and incubated at 37°C and 160 r/min until the OD 600 reached 0.4–0.6. Expression was induced with 0.1 mM ...

New and positive data for Maia Biotechnology Inc.’s lead candidate for a particularly deadly and advanced lung cancer propelled the stock modestly higher on Feb. 4. The pivotal phase II THIO-101 study ...

Gradients to optimize applications. Fast determination of thiosulfate, thiocyanate, and perchlorate. Can be used with instruments from third party manufacturers as well. Offer a wide choice of ...

If you want to know who really controls FreightCar America, Inc. (NASDAQ:RAIL), then you'll have to look at the makeup of its share registry. With 39% stake, individual investors possess the maximum ...

Although many of these compounds are yet to be evaluated in clinical trials, the recent FDA approval of sodium thiosulfate for the treatment of cisplatin-induced hearing loss in pediatric patients ...